OCT Eccentric Fixation and Amblyopia in Children

NCT ID: NCT05714449

Last Updated: 2024-04-23

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

30 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-01-25

Study Completion Date

2026-01-24

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The objectives of this proposal are to characterize the relationship between OCT eccentric fixation (OCT-EF), fixation eye movement (FEM), macular sensitivity in children with amblyopia.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Aim 1. OCT EF changes with patching treatment at 12 weeks visit.

Aim 2. OCT EF changes with foveation therapy.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Amblyopia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Patching group

part-time patching following PEDIG guidelines.

Group Type EXPERIMENTAL

eye patch

Intervention Type DEVICE

standard amblyopia treatment

foveation therapy

After-image foveation therapy training is 10 mins; MIT training is 5 minutes.

Group Type EXPERIMENTAL

After-image and MIT trainer

Intervention Type DEVICE

Common clinical training for foveation

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

eye patch

standard amblyopia treatment

Intervention Type DEVICE

After-image and MIT trainer

Common clinical training for foveation

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. children with best-corrected visual acuity (BCVA) of 20/40 (equivalent to 0.3 logMAR) or worse in the amblyopic eye (ranging from 20/40 to 20/400), and interocular difference of BCVA was at least two logMAR lines,
2. ocular causes of amblyopia that were identified as refractive(i.e., anisometropic, strabismus, or strabismic-anisometropic.

* Anisometropia included interocular difference of spherical equivalent \>=1D or interocular difference of astigmatism cylinder magnitude \>=1D;
* strabismus included those with deviation \>=10PD or good alignment after prior strabismus surgery;
* combined type included those who meet the criteria of both anisometropia and strabismus.
* For the patching group, we will enroll 15 children with strabismic amblyopia who are prescribed patching treatment. Age: 4-12 years old.
* For the foveation therapy group, we will enroll 15 children with strabismic amblyopia who are prescribed foveation therapies. Age: 8-16 years old.

Exclusion Criteria

* born before 32 weeks gestational age;
* neurologic, developmental, or systemic illnesses known to be associated with ocular pathologies;
* congenital or acquired macular pathology.
Minimum Eligible Age

4 Years

Maximum Eligible Age

16 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

State University of New York College of Optometry

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Jingyun Wang

Associate Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Jingyun Wang

Role: PRINCIPAL_INVESTIGATOR

SUNY College of Optmetry

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

SUNY College of Optometry

New York, New York, United States

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Jingyun Wang, PhD

Role: CONTACT

2129385759

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Jingyun Wang

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

1912342

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Improving Control of Intermittent Exotropia
NCT07272005 NOT_YET_RECRUITING NA
Video Treatment for Amblyopia
NCT05439200 RECRUITING NA